NEW YORK, Feb. 10, 2020 /PRNewswire/ --
2020 US Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation This new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Companies Profiled Company Assessments
Read the full report: https://www.reportlinker.com/p05842234/?utm_source=PRN
- Abbott - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - CellSearch - Cepheid - Clinical Genomics - Decode Genetics - DiaSorin - Diazyme - Eiken Chemical - Elitech Group - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic - Janssen Diagnostics - Kyowa Medex - Leica Biosystems - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - PerkinElmer - Polymedco - Qiagen - Quest Diagnostics - Roche - Scienion - Sequenom - Siemens Healthineers - Takara Bio - Theradiag - Thermo Fisher - Tosoh - Vermillion - Wako Pure Chemicals
Read the full report: https://www.reportlinker.com/p05842234/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
Advertisement
2020 US Cancer Diagnostics Market: Supplier Shares by Test, Competitive Strategies, Volume and Sales Segment Forecasts, Emerging Technologies, Latest Instrumentation This new report is a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in the US cancer diagnostics markets; reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers. Companies Profiled Company Assessments
Advertisement
Read the full report: https://www.reportlinker.com/p05842234/?utm_source=PRN
- Abbott - Agilent Technologies - Applied Gene Technologies - Arca Biopharma - Beckman Coulter/Danaher - Becton Dickinson - bioMerieux - Bio-Rad - CellSearch - Cepheid - Clinical Genomics - Decode Genetics - DiaSorin - Diazyme - Eiken Chemical - Elitech Group - Enzo Biochem - Epigenomics - Exact Sciences - Fujirebio - Guided Therapeutics - Hologic - Janssen Diagnostics - Kyowa Medex - Leica Biosystems - Myriad Genetics - OncoLab - Ortho-Clinical Diagnostics - Panacea Pharmaceuticals - PerkinElmer - Polymedco - Qiagen - Quest Diagnostics - Roche - Scienion - Sequenom - Siemens Healthineers - Takara Bio - Theradiag - Thermo Fisher - Tosoh - Vermillion - Wako Pure Chemicals
Read the full report: https://www.reportlinker.com/p05842234/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
View original content:http://www.prnewswire.com/news-releases/2020-us-cancer-diagnostics-market-supplier-shares-by-test-competitive-strategies-volume-and-sales-segment-forecasts-emerging-technologies-latest-instrumentation-301001726.html
SOURCE Reportlinker